I am a veterinary graduate of the University of Glasgow. After completing a PhD on bovine lungworm vaccine development, I continued at Glasgow for several years teaching veterinary students and developing my own programme of research on vaccines and on the biology of cyathostomins, important pathogens of horses. In 1998, I moved to the Equine Division at the University of Liverpool where my research expanded to include the study of anthelmintic resistance and the development of diagnostic tests to support evidence based control. In 2004, I relocated to Moredun and, since then, along with my colleagues have a vaccine development programme on sheep nematodes, alongside the equine worm research. The target pathogen for the vaccine research is Teladorsagia circumcincta, the primary roundworm of small ruminants in temperate areas. My research activities have always sat alongside a strong ethos for trying to inspire under- and post-graduate students in veterinary parasitology and for disseminating knowledge and research findings to the broader community. I sit on the UK Veterinary Products Committee and am a member of the Steering Group of the Control Of Worms Sustainably in cattle initiative (http://www.cattleparasites.org.uk ). I deliver several seminars a year to farmers, horse owners and people that prescribe anthelmintics. Find out more at: http://www.moredun.org.uk/staff/professor-jacqui-matthews.

I am delighted to be coordinating PARAGONE with a consortium comprising the leading scientists in veterinary parasite vaccine development. My research in PARAGONE focuses on the further development of our T. circumcincta sub-unit vaccine, the objective being to improve the stimulation of immunity particularly in young lambs, in which effective responses to the parasite are difficult to induce. We are achieving our objectives through collaboration with a number of the PARAGONE partners in the UK, Spain and China. Close collaboration with our industrial partners, as well as the many planned activities with appropriate end-users and stakeholders, will ensure that the vaccine will be fit for purpose for uptake by veterinarians and farmers in the field.